Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness

被引:74
作者
Jeck, N
Reinalter, SC
Henne, T
Marg, W
Mallmann, R
Pasel, K
Vollmer, M
Klaus, G
Leonhardt, A
Seyberth, HW
Konrad, M
机构
[1] Univ Marburg, Dept Pediat, D-35037 Marburg, Germany
[2] Hannover Med Sch, D-3000 Hannover, Germany
[3] Hosp Sankt Jurgen Str, Bremen, Germany
[4] Elisabeth Hosp, Essen, Germany
[5] Charite, Berlin, Germany
[6] Univ Freiburg, Freiburg, Germany
关键词
tubulopathy; Bartter syndrome; polyhydramnios; renal failure; syndromic deafness; pleiotropic gene;
D O I
10.1542/peds.108.1.e5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective. To characterize a rare inherited hypokalemic salt-losing tubulopathy with linkage to chromosome 1p31. Methods. We conducted a retrospective analysis of the clinical data for 7 patients in whom cosegregation of the disease with chromosome 1p31 had been demonstrated. In addition, in 1 kindred, prenatal diagnosis in the second child was established, allowing a prospective clinical evaluation. Results. Clinical presentation of the patients was homogeneous and included premature birth attributable to polyhydramnios, severe renal salt loss, normotensive hyperreninemia, hypokalemic alkalosis, and excessive hyperprostaglandin E-uria, which suggested the diagnosis of hyperprostaglandin E syndrome/antenatal Bartter syndrome. However, the response to indomethacin was only poor, accounting for a more severe variant of the disease. The patients invariably developed chronic renal failure. The majority had extreme growth retardation, and motor development was markedly delayed. In addition, all patients turned out to be deaf. Conclusion. The hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness represents not only genetically but also clinically a disease entity distinct from hyperprostaglandin E syndrome/antenatal Bartter syndrome. A pleiotropic effect of a single gene defect is most likely causative for syndromic hearing loss.
引用
收藏
页数:9
相关论文
共 41 条
  • [11] Jeck N, 1999, AM J HUM GENET, V65, pA302
  • [12] Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndrome
    Jeck, N
    Derst, C
    Wischmeyer, E
    Ott, H
    Weber, S
    Rudin, C
    Seyberth, HW
    Daut, J
    Karschin, A
    Konrad, M
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (05) : 1803 - 1811
  • [13] Karolyi L, 1997, HUM MOL GENET, V6, P17
  • [14] Impaired response to furosemide in hyperprostaglandin E syndrome: Evidence for a tubular defect in the loop of Henle
    Kockerling, A
    Reinalter, SC
    Seyberth, HW
    [J]. JOURNAL OF PEDIATRICS, 1996, 129 (04) : 519 - 528
  • [15] Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome
    Kömhoff, M
    Jeck, NDM
    Seyberth, HW
    Gröne, HJ
    Nüsing, RM
    Breyer, MD
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (06) : 2420 - 2424
  • [16] Prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes
    Konrad, M
    Leonhardt, A
    Hensen, P
    Seyberth, HW
    Köckerling, A
    [J]. PEDIATRICS, 1999, 103 (03) : 678 - 683
  • [17] INFANTILE VARIANT OF BARTTER-SYNDROME AND SENSORINEURAL DEAFNESS - A NEW AUTOSOMAL RECESSIVE DISORDER
    LANDAU, D
    SHALEV, H
    OHALY, M
    CARMI, R
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 59 (04): : 454 - 459
  • [18] REFERENCE INTERVALS AND DEVELOPMENTAL-CHANGES IN URINARY PROSTANOID EXCRETION IN HEALTHY NEWBORNS, INFANTS AND CHILDREN
    LEONHARDT, A
    BUSCH, C
    SCHWEER, H
    SEYBERTH, HW
    [J]. ACTA PAEDIATRICA, 1992, 81 (03) : 191 - 196
  • [19] Bartter syndrome in Costa Rica: A description of 20 cases
    Madrigal, G
    Saborio, P
    Mora, F
    Rincon, G
    GuayWoodford, LM
    [J]. PEDIATRIC NEPHROLOGY, 1997, 11 (03) : 296 - 301
  • [20] MCCREDIE DA, 1974, AUST PAEDIATR J, V10, P286